232 related articles for article (PubMed ID: 35709399)
1. Polyarteritis nodosa: an evolving primary systemic vasculitis.
Springer JM; Byram K
Postgrad Med; 2023 Jan; 135(sup1):61-68. PubMed ID: 35709399
[TBL] [Abstract][Full Text] [Related]
2. Polyarteritis nodosa and deficiency of adenosine deaminase 2 - Shared genealogy, generations apart.
Huang Z; Li T; Nigrovic PA; Lee PY
Clin Immunol; 2020 Jun; 215():108411. PubMed ID: 32276138
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of childhood-onset polyarteritis nodosa and DADA2.
Kasap Cuceoglu M; Sener S; Batu ED; Kaya Akca U; Demir S; Sag E; Atalay E; Balık Z; Basaran O; Bilginer Y; Ozen S
Semin Arthritis Rheum; 2021 Jun; 51(3):559-564. PubMed ID: 33901990
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
Human A; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A; Veiga KR; Saad N
Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
[TBL] [Abstract][Full Text] [Related]
6. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
[TBL] [Abstract][Full Text] [Related]
7. Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: A narrative review.
Conticini E; Sota J; Falsetti P; Lamberti A; Miracco C; Guarnieri A; Frediani B; Cantarini L
Autoimmun Rev; 2021 Apr; 20(4):102784. PubMed ID: 33609794
[TBL] [Abstract][Full Text] [Related]
8. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of adenosine deaminase 2 (DADA2): Review.
Sharma V; Deo P; Sharma A
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous vasculitis in autoinflammatory diseases.
Chen KR
J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
[TBL] [Abstract][Full Text] [Related]
11. Polyarteritis nodosa.
Forbess L; Bannykh S
Rheum Dis Clin North Am; 2015; 41(1):33-46, vii. PubMed ID: 25399938
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.
Chasset F; Francès C
Clin Rev Allergy Immunol; 2017 Dec; 53(3):452-468. PubMed ID: 28547523
[TBL] [Abstract][Full Text] [Related]
13. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
14. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.
Schnappauf O; Sampaio Moura N; Aksentijevich I; Stoffels M; Ombrello AK; Hoffmann P; Barron K; Remmers EF; Hershfield M; Kelly SJ; ; Cuthbertson D; Carette S; Chung SA; Forbess L; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland L; Pagnoux C; Seo P; Springer JM; Sreih AG; Warrington KJ; Ytterberg SR; Kastner DL; Grayson PC; Merkel PA;
Arthritis Rheumatol; 2021 Mar; 73(3):512-519. PubMed ID: 33021335
[TBL] [Abstract][Full Text] [Related]
15. Polyarteritis Nodosa: Old Disease, New Etiologies.
Wolff L; Horisberger A; Moi L; Karampetsou MP; Comte D
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068989
[TBL] [Abstract][Full Text] [Related]
16. Polyarteritis nodosa revisited.
Colmegna I; Maldonado-Cocco JA
Curr Rheumatol Rep; 2005 Aug; 7(4):288-96. PubMed ID: 16045832
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
18. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
[TBL] [Abstract][Full Text] [Related]
19. [The changing face of medium-sized vasculitis].
Parada-Turska J; Turska M
Wiad Lek; 2018; 71(1 pt 1):64-72. PubMed ID: 29558354
[TBL] [Abstract][Full Text] [Related]
20. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome.
Lhote F; Cohen P; Guillevin L
Lupus; 1998; 7(4):238-58. PubMed ID: 9643314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
